Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges
- PMID: 22851492
- DOI: 10.1210/jc.2012-1616
Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges
Abstract
Context: Central hypothyroidism (CH) is a particular hypothyroid condition due to an insufficient stimulation by TSH of an otherwise normal thyroid gland. This condition raises several challenges for clinicians; therefore, a review of the most relevant findings on CH epidemiology, pathogenesis, and clinical management has been performed.
Methodology: The relevant papers were selected by a PubMed search using appropriate key words.
Main findings: CH can be the consequence of various disorders affecting either the pituitary gland or the hypothalamus, but most frequently affecting both of them. CH is about 1000-fold rarer than primary hypothyroidism. Except for the neonatal CH due to biallelic TSHβ mutations, the thyroid hormone defect is rarely as profound as can be observed in some primary forms. In contrast with primary hypothyroidism, CH is most frequently characterized by low/normal TSH levels, and adequate thyroid hormone replacement is associated with the suppression of residual TSH secretion. Thus, CH often represents a clinical challenge because physicians cannot rely on the systematic use of the "reflex TSH strategy." The clinical management of CH is further complicated by the frequent combination with other pituitary deficiencies and their substitution.
Similar articles
-
Diagnostic and therapeutic challenges of acquired thyrotropic deficiency.Ann Endocrinol (Paris). 2012 Apr;73(2):138-40. doi: 10.1016/j.ando.2012.04.004. Epub 2012 Apr 26. Ann Endocrinol (Paris). 2012. PMID: 22541997 Review.
-
Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: hypothyroidism.Handb Clin Neurol. 2014;124:397-405. doi: 10.1016/B978-0-444-59602-4.00027-7. Handb Clin Neurol. 2014. PMID: 25248602 Review.
-
The diagnosis and management of central hypothyroidism in 2018.Endocr Connect. 2019 Feb;8(2):R44-R54. doi: 10.1530/EC-18-0515. Endocr Connect. 2019. PMID: 30645189 Free PMC article. Review.
-
The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.J Clin Endocrinol Metab. 2000 Aug;85(8):2722-7. doi: 10.1210/jcem.85.8.6718. J Clin Endocrinol Metab. 2000. PMID: 10946871
-
Central hypothyroidism and growth hormone treatment: clinical care.J Endocrinol Invest. 2008 Sep;31(9 Suppl):66-70. J Endocrinol Invest. 2008. PMID: 19020390 Review.
Cited by
-
Thyroid Hormones and Co-workers: An Overview.Methods Mol Biol. 2025;2876:3-16. doi: 10.1007/978-1-0716-4252-8_1. Methods Mol Biol. 2025. PMID: 39579305 Review.
-
Novel insights into the pleiotropic health effects of growth differentiation factor 11 gained from genome-wide association studies in population biobanks.BMC Genomics. 2024 Sep 6;25(1):837. doi: 10.1186/s12864-024-10710-7. BMC Genomics. 2024. PMID: 39237910 Free PMC article.
-
Pituitary deficiencies related to optic nerve hypoplasia and visual acuity.Clin Endocrinol (Oxf). 2024 Nov;101(5):507-515. doi: 10.1111/cen.15125. Epub 2024 Aug 4. Clin Endocrinol (Oxf). 2024. PMID: 39099207 Free PMC article.
-
Frequency and Determinants of Depression in Hypothyroidism Patients at a Tertiary Care Hospital in the Western Region of Saudi Arabia.Saudi J Med Med Sci. 2024 Jul-Sep;12(3):259-265. doi: 10.4103/sjmms.sjmms_261_23. Epub 2024 Jun 20. Saudi J Med Med Sci. 2024. PMID: 39055073 Free PMC article.
-
Capsiate ameliorates secondary hyperparathyroidism by improving insulin sensitivity and inhibiting angiogenesis.J Cell Mol Med. 2024 Apr;28(8):e18202. doi: 10.1111/jcmm.18202. J Cell Mol Med. 2024. PMID: 38591872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
